Morten A Karsdal
Overview
Explore the profile of Morten A Karsdal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
319
Citations
5888
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kaps L, Genc M, Moehler M, Grabbe S, Schattenberg J, Schuppan D, et al.
BMC Gastroenterol
. 2025 Feb;
25(1):53.
PMID: 39905306
Background: The collagen-rich tumor stroma plays a crucial role in biliary tract cancer (BTC). Collagen biomarkers of type I collagen (reC1M), type III collagen (PRO-C3), type IV collagen (C4G), type...
2.
Alkaff F, Kremer D, Thaunat O, Berger S, van den Born J, Genovese F, et al.
Transplant Direct
. 2025 Jan;
10(3):e1591.
PMID: 39877646
Background: Kidney fibrosis is a suggested cause of kidney failure and premature mortality. Because collagen type VI is closely linked to kidney fibrosis, we aimed to evaluate whether urinary endotrophin,...
3.
Pillay J, Flikweert A, van Meurs M, Grootenboers M, van der Sar-van der Brugge S, van der Voort P, et al.
Respir Res
. 2025 Jan;
26(1):32.
PMID: 39844140
Background: Severe and critical COVID-19 is characterized by pulmonary viral infection with SARS-CoV-2 resulting in local and systemic inflammation. Dexamethasone (DEX) has been shown to improve outcomes in critically ill...
4.
Aberrant basement membrane production by HSCs in MASLD is attenuated by the bile acid analog INT-767
Ramachandran P, Brice M, Sutherland E, Hoy A, Papachristoforou E, Jia L, et al.
Hepatol Commun
. 2024 Nov;
8(12).
PMID: 39585303
Background: The farnesoid X receptor (FXR) is a leading therapeutic target for metabolic dysfunction-associated steatohepatitis (MASH)-related fibrosis. INT-767, a potent FXR agonist, has shown promise in preclinical models. We aimed...
5.
Hannani M, Thudium C, Gellhorn A, Larkin J, Karsdal M, Lisowska-Petersen Z, et al.
Osteoarthritis Cartilage
. 2024 Nov;
33(1):166-175.
PMID: 39522936
Objective: To assess the longitudinal stability of biomarker-based molecular endotypes of knee osteoarthritis (KOA) participants from APPROACH and to evaluate the consistency of findings in an independent KOA population. Methods:...
6.
Thudium C, Rasmussen S, Karsdal M, Bay-Jensen A
Osteoarthr Cartil Open
. 2024 Nov;
6(4):100527.
PMID: 39502930
Objective: The development of disease-modifying drugs is limited by OA's heterogeneity and the challenge of defining clinical endpoints. Serological biomarkers are considered potential surrogate endpoints, but their contribution from single...
7.
Poulsen A, Alexdottir M, Riis L, Pehrsson M, Sorensen L, Krarup P, et al.
Inflamm Bowel Dis
. 2024 Oct;
31(3):751-762.
PMID: 39437199
Background: Ulcerative colitis (UC) is characterized by recurrent inflammation and challenging disease monitoring, with invasive endoscopy as the primary diagnostic tool despite the inadequacy of standard noninvasive biomarkers. This study...
8.
Crespo-Bravo M, Hettich A, Thorlacius-Ussing J, Cox T, Karsdal M, Willumsen N
Clin Exp Med
. 2024 Jul;
24(1):166.
PMID: 39048763
Understanding the tumor microenvironment (TME) and extracellular matrix (ECM) is crucial in cancer research due to their impact on tumor progression. Collagens, major ECM components, regulate cell signaling and behavior....
9.
Fainberg H, Moodley Y, Triguero I, Corte T, Sand J, Leeming D, et al.
Lancet Respir Med
. 2024 Jul;
12(9):681-692.
PMID: 39025091
Background: Pulmonary fibrosis results from alveolar injury, leading to extracellular matrix remodelling and impaired lung function. This study aimed to classify patients with pulmonary fibrosis according to blood biomarkers to...
10.
Rasmussen D, Hansen M, Frederiksen P, Luo Y, Pehrsson M, Neal B, et al.
Diabetes Obes Metab
. 2024 Jul;
26(9):4060-4068.
PMID: 39014523
Aim: To investigate type III collagen (COL III) turnover in participants from the CANVAS Program biomarker substudy. Methods: Biomarkers of COL III formation (PRO-C3) and COL III degradation fragments (C3M...